Meanwhile, we examined the protein expression levels of the P62-Keap1-Nrf2 pathway and its downstream target genes, HMOX1 and NQO1, following combination treatment with PAH and Fer-1 or PAH and RSL3. The gene discussed is KEAP1; the disease is pulmonary arterial hypertension.